Christopher Ryerson

Dr. Chris Ryerson completed his core clinical training at UBC and a pulmonary fibrosis fellowship and Masters degree in clinical research at the University of California San Francisco before joining UBC faculty in 2011. He is an Associate Professor at UBC, director of the St. Paul’s Hospital pulmonary fibrosis clinical and research program, and Head of the Division of Respiratory Medicine at Providence Health Care. He is a recent recipient of the Distinguished Achievement Award for Excellence in Clinical or Applied Research from the UBC Faculty of Medicine.

Dr. Ryerson’s research focuses on management and prognostication of pulmonary fibrosis. This includes recent work on frailty and body composition as well as several studies exploring the benefits of oxygen supplementation in patients with pulmonary fibrosis and optimal strategies for its use. Dr. Ryerson leads the Canadian Registry for Pulmonary Fibrosis (CARE-PF), an 8-centre prospective registry that is among the largest in the world, as well as the HOPE-IPF study, which is a randomized controlled trial evaluating the clinical and physiological impact of oxygen supplementation during exercise training in 88 patients with idiopathic pulmonary fibrosis. Dr. Ryerson has also been involved in several national and international clinical practice guidelines on the diagnosis and management of pulmonary fibrosis.

For an up-to-date list of publications by Dr. Ryerson, please see NCBI.